| Literature DB >> 35354014 |
Edana Mann1, Daniel Swedien1, Jonathan Hansen1, Susan Peterson1,2, Mustapha Saheed1, Eili Klein1, Ajit Munjuluru1, James Scheulen1, Gabor Kelen1,3,2.
Abstract
INTRODUCTION: Nationally, there has been more than a 40% decrease in Emergency Department (ED) patient volume during the coronavirus disease 2019 (Covid-19) crisis, with reports of decreases in presentations of time-sensitive acute illnesses. We analyzed ED clinical presentations in a Maryland/District of Columbia regional hospital system while health mitigation measures were instituted.Entities:
Mesh:
Year: 2021 PMID: 35354014 PMCID: PMC8328168 DOI: 10.5811/westjem.2020.10.49759
Source DB: PubMed Journal: West J Emerg Med ISSN: 1936-900X
Figure 1Johns Hopkins Health System (JHHS). Hospital Emergency Departments in Red. Adapted from google map.16
Figure 2Johns Hopkins Health System ED Visits, March 16 – May 15, 2016 – 2020, respectively.
Patient demographics by age, gender, race, and ethnicity for time period, March 16 to May 15; 2019 compared with 2020.
| 03/16/19 to 05/15/19 | 03/16/20 to 05/15/20 | Change in patient visits, 2019 to 2020 | P -Value | ||
|---|---|---|---|---|---|
| N = | N = | N = | (% =) | ||
| Total | 43,088 | 27,293 | −15,795 | (−36.7%) | <.001 |
| Age | |||||
| 15–24 | 4,233 | 2,395 | −1,838 | (−43.4%) | <.001 |
| 25–34 | 7,705 | 4,970 | −2,735 | (−35.5%) | <.001 |
| 35–44 | 6,552 | 4,525 | −2,027 | (−30.9%) | <.001 |
| 45–54 | 6,607 | 4,327 | −2,280 | (−34.5%) | <.001 |
| 55–64 | 6,691 | 4,508 | −2,183 | (−32.6%) | <.001 |
| 65–74 | 5,035 | 3,050 | −1,985 | (−39.4%) | <.001 |
| 75+ | 6,246 | 3,498 | −2,748 | (−44%) | <.001 |
| Unknown | 19 | 20 | 1 | (5.3%) | 1.00 |
| Sex | |||||
| Male | 19,917 | 13,814 | −6,103 | (−30.6%) | <.001 |
| Female | 23,164 | 13,462 | −9,702 | (−41.9%) | <.001 |
| Other or not specified | 7 | 17 | 10 | (142.9%) | 0.06 |
| Race (self-identified) | |||||
| American Indian or Alaska Native | 60 | 34 | −26 | (−43.3%) | 0.01 |
| Asian | 1,492 | 930 | −562 | (−37.7%) | <.001 |
| Black or African American | 16,889 | 10,918 | −5,971 | (−35.4%) | <.001 |
| Native Hawaiian or Pacific Islander | 27 | 28 | 1 | (3.7%) | 1.00 |
| White or Caucasian | 19,562 | 10,989 | −8,573 | (−43.8%) | <.001 |
| Two or more races | 699 | 485 | −214 | (−30.6%) | <.001 |
| Other or not specified | 4,359 | 3,909 | −450 | (−10.3%) | <.001 |
| Ethnicity (self-identified) | |||||
| Hispanic or Latino | 3,253 | 3,275 | 22 | (0.7%) | 0.79 |
| Not Hispanic or Latino | 39,235 | 23,693 | −15,542 | (−39.6%) | <.001 |
| Other or not specified | 600 | 325 | −275 | (−45.8%) | <.001 |
Represents change in percent within column category.
Patients’ chief complaints for time period, March 16 – May 15; 2019 compared with 2020.
| 03/16/19 – 05/15/19 | 03/16/20 – 05/15/20 | Change in volume, 2019 to 2020 | P-value | |
|---|---|---|---|---|
| N = | N = | Percent change = | ||
| Abdominal pain | 4,742 | 2,512 | −47.0% | <.001 |
| Abnormal finding | 456 | 271 | −40.6% | <.001 |
| Abscess | 250 | 110 | −56.0% | <.001 |
| Allergic | 311 | 108 | −65.3% | <.001 |
| Altered mental status | 628 | 508 | −19.1% | <.001 |
| Arrest (cardiac and/or respiratory) | 78 | 51 | −34.6% | 0.02 |
| Back pain | 1,192 | 435 | −63.5% | <.001 |
| Blunt trauma | 2,525 | 1,399 | −44.6% | <.001 |
| Burn | 144 | 91 | −36.8% | <.001 |
| Cardiovascular (general) | 69 | 15 | −78.3% | <.001 |
| Chest pain | 3,102 | 2,042 | −34.2% | <.001 |
| Collision | 1,117 | 416 | −62.8% | <.001 |
| Constitutional symptoms | 264 | 169 | −36.0% | <.001 |
| Dental | 352 | 176 | −50.0% | <.001 |
| Device | 224 | 129 | −42.4% | <.001 |
| Dizziness | 865 | 335 | −61.3% | <.001 |
| Dysrhythmia | 526 | 283 | −46.2% | <.001 |
| Edema | 501 | 193 | −61.5% | <.001 |
| Ear, nose and throat symptoms (not epistaxis) | 338 | 109 | −67.8% | <.001 |
| Environmental | 48 | 24 | −50.0% | 0.01 |
| Epistaxis | 137 | 63 | −54.0% | <.001 |
| Fever | 640 | 1,253 | 95.8% | <.001 |
| General | 580 | 399 | −31.0% | <.001 |
| Genitourinary | 1,415 | 713 | −49.6% | <.001 |
| Gastrointestinal (including bleeding) | 459 | 222 | −49.4% | <.001 |
| Glucose, abnormal | 281 | 133 | −52.7% | <.001 |
| Head trauma | 248 | 95 | −61.7% | <.001 |
| Headache | 1,165 | 542 | −53.5% | <.001 |
| Hematologic | 29 | 21 | −27.6% | #N/A |
| Hypertension | 383 | 189 | −50.7% | <.001 |
| Hypotension | 85 | 36 | −57.6% | <.001 |
| Lower respiratory infectious symptoms | 609 | 1,260 | 106.9% | <.001 |
| Medication management | 159 | 96 | −39.6% | <.001 |
| Musculoskeletal (isolated trauma) | 961 | 347 | −63.9% | <.001 |
| Musculoskeletal (non-traumatic) | 3,323 | 1,359 | −59.1% | <.001 |
| Neurologic | 657 | 422 | −35.8% | <.001 |
| Nausea, vomiting and diarrhea | 1,244 | 630 | −49.4% | <.001 |
| Ophthalmologic | 754 | 343 | −54.5% | <.001 |
| Penetrating trauma | 70 | 75 | 7.1% | 0.74 |
| Pregnancy-related | 447 | 214 | −52.1% | <.001 |
| Psychiatric | 2,052 | 1,295 | −36.9% | <.001 |
| Referral | 92 | 66 | −28.3% | 0.05 |
| Seizures | 375 | 247 | −34.1% | <.001 |
| Shortness of breath | 2,504 | 2,726 | 8.9% | 0.002 |
| Sickle cell | 196 | 103 | −47.4% | <.001 |
| Skin, nails and hair | 587 | 175 | −70.2% | <.001 |
| Social issues | 123 | 81 | −34.1% | 0.00 |
| Substance abuse | 1,170 | 674 | −42.4% | <.001 |
| Syncope | 591 | 308 | −47.9% | <.001 |
| Upper respiratory infectious symptoms | 827 | 1,825 | 120.7% | <.001 |
| Weakness | 830 | 537 | −35.3% | <.001 |
| Wound | 677 | 343 | −49.3% | <.001 |
| Wound check | 404 | 263 | −34.9% | <.001 |
| Wound surgery | 319 | 94 | −70.5% | <.001 |
| Blank, null, or missing (not mapped) | 963 | 768 | −20.2% | <.001 |
| TOTAL | 43, 088 | 27, 293 | −36.7% | <.001 |
Comparison of emergency department visits for severe illness across Johns Hopkins Health System for time period, March 16 to May 15; 2019 compared with 2020.
| ICD10 Code | 03/16/19 to 05/15/19 | 03/16/20 to 05/15/20 | Change in patient visits, 2019 to 2020 | P-Value | ||
|---|---|---|---|---|---|---|
| N = | N = | N = | (% =) | |||
| Acute myocardial infarction (MI) | ||||||
| ST- elevation MI | I21.02–I21.3 | 48 | 33 | −15 | (−31.3%) | 0.12 |
| Non-ST-elevation MI | I21.4 | 89 | 59 | −30 | (−33.7%) | 0.02 |
| Acute coronary syndrome | I21.9, I24.9 | 20 | 13 | −7 | (−35%) | 0.30 |
| Total acute for MI | 157 | 105 | −52 | (−33.1%) | 0.002 | |
| Cardiac arrest | I46.8–I46.9 | 59 | 36 | −23 | (−39%) | 0.02 |
| Stroke | ||||||
| Hemorrhagic | I60.0–I62.9 | 83 | 70 | −13 | (−15.7%) | 0.33 |
| Ischemic | I63.0–I63.9 | 201 | 164 | −37 | (−18.4%) | 0.06 |
| TOTAL FOR STROKE | 284 | 234 | −50 | (−17.6%) | 0.03 | |
| Appendicitis | K35–K37 | 126 | 107 | −19 | (−15.1%) | 0.24 |
| Venous thromboembolism | ||||||
| Deep venous thrombosis | I82.4–I82.6 | 101 | 39 | −62 | (−61.4%) | <.001 |
| Pulmonary embolism | I26 | 115 | 94 | −21 | (−18.3%) | 0.17 |
| TOTAL FOR VTE | 216 | 133 | −83 | (−38.4%) | <.001 | |
| Acute cholecystitis | K81 | 67 | 59 | −8 | (−11.9%) | 0.53 |
| Seizures | G40 | 41 | 32 | −9 | (−22%) | 0.35 |
| Gastrointestinal bleed | K92 | 290 | 179 | −111 | (−38.3%) | <.001 |
Represents change in percent within column category.